Management of Attention Deficit/Hyperactivity Disorder (ADHD) with Methylphenidate - A Brief Review

Abstract

Methylphenidate has maintained its place, as first-line choice for the pharmacotherapy of ADHD. Methylphenidate is the most commonly used psychostimulant and has proven its short and long-term efficacy in treatment of ADHD. More than 70% of the children improve with it. Excellent results particularly on cognitive manifestations of this disorder with Methylphenidate are found in most of the studies. Currently its mechanism of action and other significant aspects are being understood in a much better way. In our country its wider availability and more clinical research is suggested so that maximum number of children with ADHD can benefit from metylphenidate use.